[Alliance for Cancer Gene Therapy](https://acgtfoundation.org)

Rolling

Amount varies by project; funding goal and budget are proposed by applicant.

Supports biotech companies developing cell and gene therapies for glioblastoma and pancreatic cancer with strong clinical potential.

Only biotech companies (private or public) are eligible; proposals must focus on glioblastoma or pancreatic cancer.

--- ## Description The Alliance for Cancer Gene Therapy's Biotech Funding Program is designed to accelerate the development of cell and gene therapies targeting glioblastoma and pancreatic cancer—two solid tumor types with significant unmet clinical needs and limited investment. The program seeks projects with robust scientific foundations and clear clinical translation pathways, offering both the potential for meaningful patient benefit and financial sustainability to support further innovation. Guided by a prominent Scientific Advisory Council and Board of Directors, the program prioritizes high-impact, underfunded cancer types that face substantial barriers to clinical trial success and venture capital support. --- ## Due Dates - Rolling submissions; applications are accepted at any time. --- ## Funding Amount - Funding amounts are determined based on the applicant's proposed project budget and funding goal. - There is no fixed maximum or minimum; applicants must justify their requested amount in the application. --- ## Eligibility - Only biotech companies (private or public corporations) are eligible to apply. - Academic institutions and other organization types are not eligible. - Projects must focus on cell and gene therapy approaches for either glioblastoma or pancreatic cancer. - Eligible project stages include preclinical, IND-enabling, and clinical trial phases. - Both early-stage and more advanced projects are considered, provided there is a clearly defined path to clinical application. --- ## Application Process - Applications are submitted via the [online application form](https://acgtfoundation.org/biotech-funding-application). - Required information includes: - Company details (name, address, contact information) - Type of corporation (private/public) - Management team and scientific advisors - Corporate presentation and investor deck (PPT or PDF) - Company financial information (funds raised, current fundraising status, project funding goal) - Project details (focus area, stage, budget estimate, summary of unmet need) - Detailed proposal explaining project value, use of ACGT funding, and expected outcomes - Applicants must upload a detailed project proposal document. - For additional information or questions, prospective applicants can contact Barbara Lavery, Chief Program Officer, at blavery@acgtfoundation.org. --- ## Additional Information - Projects must demonstrate a strong scientific rationale, significant potential for clinical impact, and a clear route to the clinic. - Financial return potential is considered, as the program aims to support sustainable cycles of innovative research. - Guidance and review are provided by ACGT’s Scientific Advisory Council and Board of Directors. --- ## External Links - [Program Overview](https://acgtfoundation.org/groundbreaking-research/biotech-funding-program/) - [Application Portal](https://acgtfoundation.org/biotech-funding-application) - [Alliance for Cancer Gene Therapy Homepage](https://acgtfoundation.org) - [Contact Page](https://acgtfoundation.org/who-we-are/contact-us/) --- ## Contact Information | Name/Role | Email | Phone | |--------------------------|------------------------------|-----------------| | Barbara Lavery, Chief Program Officer | blavery@acgtfoundation.org | +1 203-358-5055 | For general inquiries, use the [ACGT contact page](https://acgtfoundation.org/who-we-are/contact-us/).

Biotech funding program

Sign in to see full grant listing